Filing Flows › GeoVax Labs (GOVX) › Q2 2025
GeoVax Labs (GOVX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 28, 2025
GeoVax Labs (GOVX) reported revenue of $852K for the second quarter 2025 (Q2 2025), +183% from a year earlier and -48% from the quarter before. Operating margin was -635.8%, net loss $5.4M (630.0% of revenue).
GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $852K | -48% | +183% |
| Operating profit | −$5.4M | — | — |
| Net earnings | −$5.4M | — | — |
| Operating cash flow | −$4.3M | — | — |
What changed
Revenue was $852K in Q2 2025, up 183% year over year and down 48% from the previous quarter.
Operating costs exceeded revenue by $5.4M, an operating margin of -635.8%. Total costs grew 17% against revenue growth of 183%. The fastest-growing cost line was General & admin (+42%). The quarter ended with a net loss of $5.4M, wider than the previous quarter's $5.4M loss.
Operating cash flow was −$4.3M. Non-cash charges added back $17K of depreciation and amortization and $293K of share-based compensation. Working capital and other items added $726K. Capital expenditures of $11K exceeded it, leaving free cash flow of −$4.3M.
Questions
What was GeoVax Labs' revenue in the second quarter 2025?
GeoVax Labs (GOVX) reported revenue of $852K for the second quarter 2025 (Q2 2025), +183% from a year earlier and -48% from the quarter before.
Was GeoVax Labs profitable in the second quarter 2025?
Operating loss was $5.4M (-635.8% of revenue) and net loss $5.4M.
Source: GeoVax Labs 10-Q on SEC EDGAR.